NCT01323985
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
- Locations
-
- GSK Investigational Site Cambridge, United Kingdom
Clinical trial condition
Explore clinical trials studying Amyloidosis. Study availability and eligibility vary by location and protocol.
NCT01323985
NCT01406314
NCT01194791
NCT02704065
NCT01273844
NCT00890552
NCT00294671
NCT01277016
NCT02953808
NCT02191826